In vivo dopamine clearance rate in rat striatum: Regulation by extracellular dopamine concentration and dopamine transporter inhibitors

Journal of Pharmacology and Experimental Therapeutics

Volumn 289, Issue 1, 1999, Pages 266-277

  Zahniser, Nancy R ^a   Larson, Gaynor A ^a   Gerhardt, Greg A ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3BETA (4 FLUOROPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; AMPHETAMINE DERIVATIVE; COCAINE; DOPAMINE; DOPAMINE UPTAKE INHIBITOR; MAZINDOL; NOMIFENSINE; VANOXERINE;

ANIMAL EXPERIMENT; ARTICLE; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOPAMINE UPTAKE; MALE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CARRIER PROTEINS; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; ELECTROCHEMISTRY; EXTRACELLULAR SPACE; KINETICS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NEOSTRIATUM; NERVE TISSUE PROTEINS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0032952775     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Andersen PH (1989) The dopamine inhibitor GBR 12909: Selectivity and molecular mechanism of action. Eur J Pharmacol 166:493-504.
2. 125I]iodophenyl)tropane-2β-carboxylic acid isopropyl ester. Mol Pharmacol 47:779-786.
3. Carroll FI, Lewin AH, Boja JW and Kuhar MJ (1992) Cocaine receptor: Biochemical characterization and structure-activity relationships of cocaine analogues at the dopamine transporter. J Med Chem 35:969-981.
4. Cass WA, Gerhardt GA, Gillespie K, Curella P, Mayfield RD and Zahniser NR (1993a) Reduced clearance of exogenous dopamine in rat nucleus accumbens, but not in dorsal striatum, following cocaine challenge in rats withdrawn from repeated cocaine administration. J Neurochem 61:273-283.
5. Cass WA, Gerhardt GA, Mayfield RD, Curella P and Zahniser NR (1992) Differences in dopamine clearance and diffusion in rat striatum and nucleus accumbens following cocaine administration. J Neurochem 59:259-266.
6. Cass WA, Zahniser NR, Flach KA and Gerhardt GA (1993b) Clearance of exogenous dopamine in rat dorsal striatum and nucleus accumbens: Role of metabolism and effects of locally applied uptake inhibitors. J Neurochem 61:2269-2278.
7. Church WH, Justice JB Jr and Byrd LD (1987) Extracellular dopamine in rat striatum following uptake inhibition by cocaine, nomifensitie and benztropine. Eur J Pharmacol 139:345-348.
8. 3 receptors. J Neurosci 18:6528-6538.
9. 3H] nomifensine to striatal membranes. Biochem Pharmacol 34:1137-1144.
10. Eshleman AJ, Henningsen RA, Neve KA and Janowsky A (1994) Release of dopamine via the human transporter. Mol Pharmacol 45:312-316.
11. Ewing AG and Wightman RM (1984) Monitoring the stimulated release of dopamine with in vivo voltammetry. II. Clearance of released dopamine from extracellular fluid. J Neurochem 43:570-577.
12. Foltin RW and Fischman MW (1991) Assessment of abuse liability of stimulant drugs in humans: A methodological survey. Drug Alcohol Depend 28:3-48.
13. Friedemann MN and Gerhardt GA (1992) Regional effects of aging on dopaminergic function in the Fisher-344 rat. Neurobiol Aging 13:325-332.
14. Garnis PA, Christensen JRC, Rebec GV and Wightman RM (1997) Real-time measurement of electrically evoked extracellular dopamine in the striatum of freely moving rats. J Neurochem 68:152-161.
15. Gratton A, Hoffer BJ and Gerhardt GA (1988) Effects of electrical stimulation of brain reward sites on release of dopamine in rat; An in vivo electrochemical study. Brain Res Bull 21:319-324.
16. Horn AS (1990) Dopamine uptake: A review of progress in the last decade. Prog Neurobiol (Oxford) 34:387-400.
17. Hyttel J (1982) Citalopram - Pharmacological profile of a specific serotonin uptake inhibitor with antidepressanl activity. Prog Neuro-Psychopharmacol Biol Psychiatry 6:277-295.
18. 3H]Mazindol binding associated with neuronal dopamine and norepinephrine uptake sites. Mol Pharmacol 26:35-44.
19. Jones SR, Garris PA, Kilts CD and Wightman RM (1995b) Comparison of dopamine uptake in the basolateral amygdaloid nucleus, caudate-putamen, and nucleus accumbens of the rat. J Neurochem 64:2581-2589.
20. Jones SR, Garris PA and Wightman RM (1995a) Different effects of cocaine and nomifensine on dopamine uptake in the caudate-putamen and nucleus accumbens. J Pharmacol Exp Ther 274:396-403.
21. Kuczenski R and Segal DS (1992) Differential effects of amphetamine and dopamine uptake blockers (cocaine, nomifensine) on caudate and accumbens dialysate dopamine and 3-methoxytyramine. J Pharmacol Exp Ther 262:1085-1094.
22. Kuczenski R, Segal DS and Aizenstein ML (1991) Amphetamine, cocaine, and fencamfamine: Relationship between locomotor and stereotypy profiles and caudate and accumbens dopamine dynamics. J Neurosci 11:2703-2712.
23. May LJ, Kuhr WG and Wightman RM (1988) Differentiation of dopamine overflow and uptake process in the extracellular fluid of the rat caudate nucleus with fast-scan in vivo voltammetry. J Neurochem 51:1060-1069.
24. Meiergerd SM and Schenk JO (1994) Kinetic evaluation of the commonality between the site(s) of action of cocaine and some other structurally similar and dissimilar inhibitors of the striatal transporter for dopamine. J Neurochem 63:1683-1692.
25. Ng JP, Menacherry SD, Liem BJ, Anderson D, Singer M and Justice JB Jr (1992) Anomalous effect of mazindol on dopamine uptake as measured by in vivo voltammetry and microdialysis. Neurosci Lett 134:229-232.
26. Nicholson C (1985) Diffusion from an injected volume of a substance in brain tissue with arbitrary volume fraction and tortuosity. Brain Res 333:325-329.
27. Nicholson C (1995) Interaction between diffusion and Michaelis-Menten uptake of dopamine after iontophoresis in striatum. Biophys J 68:1699-1715.
28. Nomikos GG, Damsma G, Wenkstern D and Fibiger HC (1990) In vivo characterization of locally applied dopamine uptake inhibitors by striatal microdialysis. Synapse 6:106-112.
29. Parker EM and Cubeddu LX (1986) Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striaturn. II. Release in the presence of vesicular stores. J Pharmacol Exp Ther 237: 193-203.
30. Paxinos G and Watson C (1986) The Rat Brain in Stereotaxic Coordinates, 2nd ed., Academic Press, New York.
31. Reith MEA and Selmeci G (1992) Radiolabeling of dopamine uptake sites in mouse striatum: Comparison of binding sites for cocaine, mazindol, and GBR 12935. Naunyn-Schmiedeberg's Arch Pharmacol 345:309-318.
32. Rice ME and Nicholson C (1991) Diffusion characteristics and extracellular volume fraction during normoxia and hypoxia in slices of rat striatum. J Neurophysiol 65:264-272.
33. Ritz MC, Lamb RJ, Goldberg SR and Kuhar MJ (1987) Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science (Wash DC) 237:1219-1223.
34. Sonders MS, Zhu SJ, Zahniser NR, Kavanaugh MP and Amara SG (1997) Multiple ionic conductances of the human dopamine transporter: The actions of dopamine and psychostimulants. J Neurosci 17:960-974.
35. Stamford JA, Kruk ZL and Millar J (1986) In vivo characterization of low affinity striatal dopamine uptake: Drug inhibition profile and relation to dopaminergic innervation density. Brain Res 373:85-91.
36. Stamford JA, Kruk ZL, Millar J and Wightman RM (1984) Striatal dopamine uptake in the rat: In vivo analysis by fast cyclic voltammetry. Neurosci Lett 51:133-138.
37. Suaud-Chagny MF, Dugast C, Chergui K, Msghina M and Gonon F (1995) Uptake of dopamine released by impulse flow in the rat mesolimbic and striatal systems in vivo. J Neurochem 65:2603-2611.
38. Sulzer D, Maidment NT and Rayport S (1993) Amphetamine and other weak bases act to promote reverse transport of dopamine in ventral midbram neurons. J Neurochem 60:527-535.
39. Wightman RM, Amatore C, Engstrom RC, Hale PD, Kristensen EW, Ruhr WG and May LJ (1988) Real-time characterization of dopamine overflow and uptake in the rat striatum. Neuroscience 25:513-523.
40. Wightman RM and Zimmerman JB (1990) Control of dopamine extracellular concentration in rat striatum by impulse flow and uptake. Brain Res Rev 15:135-144.
41. Xu C and Reith MEA (1997) WIN 35,428 and mazindol are mutually exclusive in binding to the cloned human dopamine transporter. J Pharmacol Exp Ther 282:920-927.
42. Zahniser NR, Dickinson SD and Gerhardt GA (1998) High-speed chronoamperometric electrochemical measurements of dopamine clearance, in: Methods in Enzymology: Neurotransnmitter Transporters (Amara SG ed) vol. 296, pp 708-719, Academic Press, San Diego.